Fair and forward thinking. I like this one as unbiased. I still fear the end result of my TRT with a history of PC in family.
WHAT THEY MAY HAVE LEFT OUT. Is that local "saturation" occurring as due to sufficiently supported testosterone levels MAY in fact protect prostate receptors by keeping plenty of testosterone on hand for action, rather than casual excess E2, or even derivative BASTARD E3 - which might have otherwise involved its self inadvertently by premise of incidental excess availability....
(I'm stockin up on that one)
WHAT THEY MAY HAVE LEFT OUT. Is that local "saturation" occurring as due to sufficiently supported testosterone levels MAY in fact protect prostate receptors by keeping plenty of testosterone on hand for action, rather than casual excess E2, or even derivative BASTARD E3 - which might have otherwise involved its self inadvertently by premise of incidental excess availability....
(I'm stockin up on that one)
Polackwich AS, Ostrowski KA, Hedges JC. Testosterone replacement therapy and prostate health. Curr Urol Rep 2013;13(6):441-6. Testosterone Replacement Therapy and Prostate Health - Springer
There is an emerging evolution in the understanding of the relationship between the prostate and testosterone. It has long been generally believed that with testosterone replacement therapy (TRT), increasing serum testosterone levels led to prostatic growth and worsening of voiding dysfunction and associated complications. A new theory, the Saturation Model of Testosterone and its effect on the Prostate has gained attention. This theory suggests that the prostate's response to increasing levels of serum testosterone reaches a limit beyond which there is minimal effect. This model predicts that testosterone replacement therapy occurs above this saturation point, and replacing testosterone to eugonadal levels should not worsen prostate related benign disease. We evaluated the recent published data, with an emphasis on clinical studies done within the last 3 years, for the effects of testosterone supplementation on benign prostatic disease.